Stay updated on Inhaled Treprostinil in COPD-Associated PH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page.

Latest updates to the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record and related sections on the ClinicalTrials.gov page. This change affects how the page is accessed rather than the study information itself.SummaryDifference18%

- Check14 days agoChange DetectedThe page's revision label updated to v3.7.0, replacing the previous v3.6.6 in the version metadata.SummaryDifference0.0%

- Check21 days agoChange DetectedQiryat Krinitzi, Israel, 52621, was removed from the study's Israel locations. Tel Litwinsky, Israel, 52621, was added as a new site.SummaryDifference0.0%

- Check28 days agoChange DetectedThe participating sites list was updated to include Qiryat Krinitzi, Israel, 52621 and exclude Tel Litwinsky, Israel, 52621. The page revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5. This reflects a new release of the site's revision or content management update.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a new revision was published. This typically reflects behind-the-scenes fixes or updates and does not change the visible content for users.SummaryDifference0.0%

Stay in the know with updates to Inhaled Treprostinil in COPD-Associated PH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page.